A former scientist at Bayer CropScience shared confidential information with his new employer, which was used to develop commercial biopesticide products, according to a claim filed by the agricultural company.
A judge has dismissed actor Clint Eastwood’s motion to gain ownership over two diabetes patents currently assigned to Molecular Defenses Corporation.
Amgen and Roche have filed a joint patent infringement claim against Samsung’s biopharmaceutical company Bioepis.
A division of Novartis has entered into an agreement with Taiwan-based EirGenix to market a medicine which treats some cancer tumours.
The six antitrust class-action lawsuits that have been brought against AbbVie could result in more scrutiny of settlement agreements between the innovator and the biosimilar manufacturer, with potential antitrust complications.
US courts need to revisit the patentability of diagnostic tests under section 101, according to Memorial Sloan Kettering Cancer Center’s chief IP counsel.
Petitioners will continue to be able to launch litigation simultaneously before both the district court and the Patent Trial and Appeal Board, effectively having two bites at the apple, according to John Kirkland, director of IP at biopharmaceutical company Alkermes.
Eli Lilly has entered into a $35m global licensing and research agreement with biotech company Avidity Biosciences.
Enzo Life Sciences has entered into a settlement and licensing agreement with pharmaceutical companies Hologic and Grifols, ending a patent dispute between the parties.
Fresenius Kabi has submitted a petition for inter partes review of US patent number 9,856,287, a patent owned by Amgen.